Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio

On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36 countries. This is the fifth major breast cancer medication introduced by Kexing Biopharm, which further enriches its product portfolio for breast cancer treatment. […]

thaipr.net

8 ม.ค. 67

Kohler Brings Design Leadership and Smart Home Wellness Experiences to CES 2024

Kohler Co. announces its leading-edge designs, innovative new products, and smart home wellness experiences for CES 2024. Kohler’s lineup marks a continued commitment to transforming homes into personal sanctuaries for comfort, self-care, and renewal.  Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9235552-kohler-leading-edge-design-innovation-smart-home-wellness-at-ces-2024/  …

thaipr.net

8 ม.ค. 67
1 693 694 695 696 697 3,040